Mustang Bio Inc (MBIO)

Mustang Bio Inc (MBIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.1M; returns 1 day +0.2%, 1 week -1.7%, 1 year -74.3%.

Mustang Bio, Inc. (MBIO) is a clinical-stage biopharmaceutical company dedicated to developing cell and gene therapies for hard-to-treat cancers and rare genetic diseases. Its business model is heavily focused on research and development, with no commercialized products generating revenue as of fiscal year 2025 and early 2026.

Groups MBIO belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Oncology
• Gene Therapy
• Autologous Cell Therapy
• Clinical Stage
• Cancer Therapeutics
• Rare Diseases
• Immunotherapy
• Life Sciences
• R&D

MBIO financial model: income statement, cash flow and balance sheet